Navigation Links
AMD LASERS(TM) Introduces the Picasso Diode Laser
Date:4/14/2009

A BREAKTHROUGH IN LASER TECHNOLOGY - A BREAKTHROUGH IN AFFORDABILITY

INDIANAPOLIS, April 14 /PRNewswire/ -- AMD LASERS(TM), the company that builds the world's most affordable dental laser technology, today announces the launch of the Picasso soft tissue diode laser to the U.S. dental industry. With its sleek and compact design, ease of use, comprehensive clinical results and a broad spectrum of applications, Picasso sets itself apart as a high-quality laser with distinctive features such as a multiple language menu and a lower price point than any other laser available on the market.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090414/DE98219 )

"I am excited to be the first company to give dentists and patients the laser technology they have been waiting for. AMD LASERS is committed to bringing lasers to every dental office and to every operatory around the world. Dental patients need laser technology now more than ever," said Alan Miller, President of AMD LASERS. "Picasso represents a breakthrough in technology and affordability. We are taking a leadership and pioneering role in dental lasers that no other company has - our mission is to place lasers in the hands of dentists and hygienists around the world. Our multi-language laser truly represents our commitment to dentists and patients."

The Picasso is ideal for a wide range of endodontic, periodontic and dental surgery procedures. It allows for clean cutting and hemostasis in a wide range of soft tissue procedures and cuts gum tissue with precision thereby eliminating bleeding at the site and reducing healing time. Picasso is also being used to help sterilize canals in endodontics, treat periodontal disease and aid in tooth whitening. Highlights of the new laser inclu
'/>"/>

SOURCE AMD LASERS(TM), LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Amoena Introduces First Post Surgical Garments With Vitamin E & Aloe to Help Soothe and Comfort After Breast Surgery
2. Blue Cross and Blue Shield of Florida Introduces BlueMedicare(SM) Group Supplement
3. Passlogix Introduces Industry's Fastest Sign-On to Kiosks with New Enhancements to v-GO Session Manager
4. Sentillion Introduces Advanced Authentication Solution For Direct Access to Cerner, Eclipsys, Epic, McKesson and MEDITECH Applications
5. Vinpower Digital Introduces Series of Standalone 8X Blu-ray Disc Duplicators with LightScribe Printing Capability
6. Allscripts Introduces SaaS Solution for Prenatal Care
7. Allscripts Introduces Electronic Health Record Capability for iPhone(TM)
8. Covaris Introduces DNA Shearing Service
9. Heavenly Essence Introduces Pureity - the Only Line of Hair Care Products That Really Cares About You
10. Schreiner ProTech Introduces Intelligent Marking Solutions Achieving Process and Cost Optimizations
11. Bipartisan Policy Center Founder Bob Dole Introduces Governor Sebelius at Confirmation Hearing to Be Next HHS Secretary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2015)... 30, 2015 This year the ... Pulmonary Horizons to offer one of the most diverse ... discuss successful practices to diagnose, treat and manage patients ... Pulmonary Horizons Conference is Interaction with Multidisciplinary Healthcare ... Overall Needs of Patients with COPD," said Brian W. ...
(Date:5/30/2015)... May 30, 2015 A live auction ... medical equipment from hospitals, surgery centers and other medical ... will be sold including radiology, surgery, endoscopy, lab, anesthesia, ... will take place Tuesday, June 2nd starting at 10:00am ... located at 5025 North Hiatus Rd., Sunrise, FL 33351. ...
(Date:5/30/2015)... NY (PRWEB) May 30, 2015 The ... May 26th 2015, announcing that, “criminals used taxpayer-specific data ... information on approximately 100,000 tax accounts through IRS’ “Get ... of birth and street address.” , “You don’t ... to have to think it was only a matter ...
(Date:5/29/2015)... “In the current environment of ... regulations, we provide education that will help practitioners ... suffering from pain, within the boundaries of the ... of rehabilitation medicine and President/Medical Director of the ... , A new flight of PAINWeekEnd Regional Conferences ...
(Date:5/29/2015)... FL (PRWEB) May 29, 2015 Ready to ... it’s important for all drivers to get their vehicles ready. ... to be prepared. Advanced Driving Systems (ADS) is ready to ... tips on preparing for summer road trips. , When planning ... the following to ensure that the trip goes smoothly and ...
Breaking Medicine News(10 mins):Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 2Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 3Health News:Centurion to Sell Surplus Medical Equipment in Online and On-site Auction 2Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 2Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 3Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 4Health News:IRS Attack Exemplifies the Compounding Dangers of Stolen Personal Data 5Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3
... , NASHVILLE, Tenn., Aug. 24 China Healthcare Corporation, ... build a state-of-the-art, 500-bed replacement hospital in Cixi, China. , ... by Dr. Thomas F. Frist, Jr., Charles A. Elcan and Henry ... for its first hospital, a full-service, acute care facility that will ...
... study shows , MONDAY, Aug. 24 (HealthDay News) -- High ... people over 45, a new study finds. , "A number ... pressure and cognitive function," said George Howard, chairman of the ... School of Public Health, and a member of the team ...
... , , WASHINGTON, Aug. 24 Nick Jonas ... the National Press Club asking them to raise more awareness about ... families to properly manage their condition. Nick, 16, is one ... He talked about his own journey with diabetes, the charitable ...
... report shows , MONDAY, Aug. 24 (HealthDay News) -- Smokers ... (TB), a new study shows. , Researchers analyzed data from ... Health Interview Survey. They found that current smokers had a ... the risk for people who had smoked at some point ...
... , ATLANTA and BRIDGEWATER, N.J., Aug. ... U.S. Food and Drug Administration (FDA) has approved XYZAL(R) (levocetirizine ... relief of symptoms of perennial allergic rhinitis (indoor allergies) and ... years and older for symptoms of seasonal allergic rhinitis (outdoor ...
... , LOS ANGELES, Aug. 24 Gerontology students ... citizens" on Friday thanks to Trading Ages(TM), an interactive senior sensitivity ... a workshop that provides participants the opportunity to literally "walk in ... exercises and sensory perception education. , , ...
Cached Medicine News:Health News:Hypertension Linked to Thinking Problems in Middle Age 2Health News:Hypertension Linked to Thinking Problems in Middle Age 3Health News:Nick Jonas Speaks at National Press Club in Effort to Educate, Support, and Inspire Kids With Diabetes 2Health News:Nick Jonas Speaks at National Press Club in Effort to Educate, Support, and Inspire Kids With Diabetes 3Health News:Nick Jonas Speaks at National Press Club in Effort to Educate, Support, and Inspire Kids With Diabetes 4Health News:Smokers Twice As Likely to Get TB 2Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 2Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 3Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 4Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 5Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 6Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 7Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 8Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 9Health News:FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria 10Health News:USC Gerontology Students Participate in 'Aging Sensitivity Training' Provided by SCAN Health Plan 2
(Date:5/30/2015)... SPARTANBURG , Carolina del Sur , ... Nueva colaboración para ampliar drásticamente el acceso al ... los Estados Unidos   La ... los pacientes con cáncer apoyo de decisión clínica ... y Molecular Health han anunciado una colaboración diseñada ...
(Date:5/30/2015)... 30, 2015  Eisai Inc. announced today the results of ... met the study,s primary endpoint evaluating overall survival in patients ... types of advanced soft tissue sarcoma. These data will be ... American Society of Clinical Oncology (ASCO) in Chicago ... Saturday, May 30, and also in an oral session on ...
(Date:5/30/2015)... 2015 Caris Life Sciences®, a leading ... precision medicine, today announced the presentation of data ... Caris Molecular Intelligence®, the company,s panomic comprehensive tumor ... share histological features. In separate presentations at the ... Oncology (ASCO) in Chicago, Ill. ...
Breaking Medicine Technology:Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 2Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 3Nueva colaboración para ampliar el acceso al ensayo clínico terapéutico para pacientes con cáncer en EEUU 4Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 2Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 3Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 4Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 5Phase 3 Trial Investigating Eribulin in Patients with Advanced Soft Tissue Sarcoma Demonstrated Improved Overall Survival 6Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 2Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 3Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 4Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 5Caris Molecular Intelligence Multi-Platform Tumor Profiling Facilitates Comparisons between Tumors that Share Histological Features 6
... - Initial clinical trial results suggesting safety and ... the AACR-NCI-EORTC International Conference -, BRANFORD, Conn., ... a clinical-stage biopharmaceutical company focused on,oncology, announced that ... CR011-,vcMMAE, an antibody-drug conjugate (ADC) being developed for ...
... of Two Major Clinical Studies TAX 323 and ... Sanofi-aventis,announced today that results of two clinical ... to cisplatin and,5- fluorouracil for induction therapy, significantly ... squamous cell carcinoma of,the head and neck (SCCHN) ...
Cached Medicine Technology:CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma 2CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma 3CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma 4CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma 5CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma 6Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 2Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 3Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 4Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 5Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 6Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine 7
ACMI™ COAG Bipolar Laparoscopy Probes provide 360 of hemostatis, bipolar safety, blunt dissection, irrigation, and suction in one instrument....
... vitro Nucleic Acid Hybridization Assay ... Chemiluminescence for the Qualitative Detection ... 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and 68 and Analysis ... Groups in Cervical Specimens: HPV ...
An In Vitro Nucleic Acid Hybridization Assay with Signal Amplification using Microplate Chemiluminescence for the Qualitative Detection of Human Papillomavirus (HPV) Types 16, 18, 31, 33, 35, 39, 45,...
... AS100 Analyzer is designed ... regardless of the sample ... launched in December 2004, ... in May 2005. Assays ...
Medicine Products: